Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Point Of Care Hematology Diagnostics Market Set To Climb From $3.16 Billion In 2026 To $4.39 Billion By 2030#_x000D_
The point of care hematology diagnostics market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $2.9 billion in 2025 to $3.16 billion in 2026, registering a compound annual growth rate (CAGR) of 9.0%. Its historical growth was influenced by factors including reliance on centralized laboratory testing, the escalating prevalence of anemia and blood disorders, a rise in hospital emergency admissions, the demand for expedited diagnostic turnaround times, and restricted access to laboratory infrastructure in rural areas._x000D_
_x000D_
The point of care hematology diagnostics market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $4.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by several factors, including the increasing incidence of chronic and infectious diseases, the expansion of point of care testing initiatives, a heightened need for swift diagnostics in emergency situations, innovations in compact hematology analyzers, and the proliferation of decentralized healthcare delivery systems. Key trends expected over the forecast period encompass a greater uptake of rapid bedside blood testing, an increasing requirement for decentralized diagnostics in urgent care environments, the wider deployment of portable and handheld hematology instruments, the extension of point of care testing into regions with limited resources, and an emphasis on reducing turnaround times for quicker clinical decision-making._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Point Of Care Hematology Diagnostics Market Development Factors: What’s Supporting Demand?#_x000D_
The growing prevalence of blood disorders is expected to drive the expansion of the point-of-care hematology diagnostics market in the future. Blood disorders are defined as conditions that impact the blood’s components, such as red blood cells, white blood cells, platelets, or plasma. This increasing incidence of blood disorders is primarily linked to the rising occurrence of chronic diseases, which directly affect blood health and require continuous monitoring. Point-of-care hematology diagnostics assist in the early detection and management of blood disorders by offering rapid, accurate results directly at or near the patient’s location, enabling quicker clinical decisions and improved disease management. For instance, in November 2024, The American Society of Hematology, a US-based Non-profit organization, projected that global leukemia cases could reach approximately 519,540 by 2050. Therefore, the increasing incidence of blood disorders is a key factor boosting the growth of the point-of-care hematology diagnostics market._x000D_
_x000D_
#Point Of Care Hematology Diagnostics Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The point of care hematology diagnostics market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types_x000D_
2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product_x000D_
3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)_x000D_
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level_x000D_
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin_x000D_
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation_x000D_
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing_x000D_
_x000D_
#Point Of Care Hematology Diagnostics Market Transformation Trends: What Innovations Are Driving Change?#_x000D_
Leading companies in the point-of-care hematology diagnostics market are prioritizing the creation of innovative solutions, such as cartridge-based AI-powered hematology analyzers, to provide swift, precise, and immediate blood testing for enhanced patient outcomes. These analyzers are characterized as compact diagnostic instruments that employ disposable reagent cartridges and artificial intelligence technology for the rapid and precise examination of blood specimens directly where care is given. An example of this is Zoetis Inc., a US-based veterinary health company, which in September 2024 introduced Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer tailored for animal health applications. This advanced device provides swift and high-standard complete blood count (CBC) outcomes on-site in a matter of minutes, simultaneously minimizing upkeep and operational effort. Featuring sophisticated AI-powered image processing and viscoelastic focusing capabilities, it accurately positions cells for optimal visualization, facilitating precise blood cell categorization and automatic detection of irregularities, consequently guaranteeing effective and dependable diagnostic results for animals._x000D_
_x000D_
#Point Of Care Hematology Diagnostics Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio‑Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio‑Rad Laboratories Inc. _x000D_
_x000D_
#View The Full Point Of Care Hematology Diagnostics Market Report:#_x000D_
_x000D_
#Point Of Care Hematology Diagnostics Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_
North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.